TCL Archive Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker October 3, 2014
TCL Archive Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials December 2, 1977
TCL Archive USC Scientists Says It’s Time Nobelists Recognize Value of Cancer Program February 10, 1978
TCL Archive NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say. April 16, 2004
